appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Lincoln Pharmaceuticals Ltd
LINCOLN
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Lincoln Pharmaceuticals Ltd achieves the milestone of Rs. 533 crore Revenue and Rs. 100 crore Profit before Tax for the first time in a Financial Year for FY2022-23
4 days ago•Free Press Journal
Sensex, Nifty settle higher in volatile trade; AEL & Bajaj Auto rises 3% each; Lincoln Pharma falls 11%
1 week ago•Business Today
Lincoln Pharmaceuticals Reports Strong Profit Growth and Dividend Recommendation
1 week ago•The Hindu Businessline
Lincoln Pharmaceuticals stock price at All time high
2 weeks ago•Free Press Journal
Stock market update: Stocks that hit 52-week highs on NSE
2 weeks ago•Economic Times
Recent EventsAll events
Updates
Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of placing of the matter before the Board of Directors w.r.t Identification of non-compliance of regulation 17(1) of SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 ( Listing Regulations ) and subsequent action taken by the exchange in the matter'. | Download
Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of placing of the matter before the Board of Directors w.r.t Identification of non-compliance of regulation 17(1) of SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 ( Listing Regulations ) and subsequent action taken by the exchange in the matter'. | Download
Cash Dividend
Final • Div/Share: ₹ 1.5
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 2.92%